© Borgis - New Medicine 1/2014, s. 29-32
*Mihály Dió1, Tibor Deutsch1, Judit Mèszáros2
An educational model of glucose homeostasis in diabetes mellitus
1Department of Medical Imaging and Technology, Faculty of Health Sciences, Semmelweis University, Budapest, Hungary
Head of Department: Éva Kis, PhD
2Faculty of Health Sciences, Semmelweis University, Budapest, Hungary
Head of the Faculty: prof. Zoltán Zsolt Nagy, PhD
A simulation model of glucose homeostasis in diabetes mellitus could be very useful for patient, student and health-carer training. In this paper, the first design phase of the modelling work is presented. The new comprehensive educational model of glucose homeostasis described in this report attempts to provide an anatomically explicit basis for simulations that incorporates up-to-date quantitative knowledge about glucose metabolism and its control by insulin. The overall glucose homeostasis model consists of differential mass balance equations complemented by differential or algebraic relationships for each metabolic source or sink term. Major clinical parameters such as basal glucose and insulin levels along with hepatic glucose production are used for customizing the model for individual patients. The educational model allows the simulation of 24-hour blood glucose (BG) profiles for non-diabetic subjects as well as for people with insulin-dependent (type 1) diabetes mellitus (IDDM) and non-insulin dependent (type 2) diabetes mellitus (NIDDM). Graphs of the model functions are provided, and example simulations are shown demonstrating the inner workings of the model.
Diabetes mellitus is a syndrome of impaired carbohydrate, fat, and protein metabolism caused by either a lack of insulin secretion or decreased sensitivity of the tissue to insulin. For people with insulin-dependent (type 1) diabetes mellitus (IDDM), insulin must be provided from an exogenous source other than the pancreas. People with NIDDM may also end up requiring insulin.
Insulin requiring patients should adjust their insulin dose(s) according to their blood sugars and in relation to various lifestyle events. This represents a daily challenge, as many factors influence glycaemia, such as diet, meal composition, and exercise, as well as stress. Often diabetic patients have developed their skills by some trial-and-error-like training over a long period of time. The task is non-trivial, and many patients would benefit from some sort of educational support. Learning how to modulate insulin therapy in relation to food intake and insulin injections to prevent out-of-target BG deviations would be very useful. However, education of people with diabetes requires a level of clinical expertise which although present in specialised diabetes units, and some general practices with an interest in diabetes, is not always to be found in other sectors of the health service.
The working hypothesis underlying the interactive educational diabetes simulation approach has been that enabling people to try out different therapeutic and dietary alternatives can help them to gain experience in achieving glycaemic control, without the risks of actually experiencing hypoglycaemic or hyperglycaemic episodes. With the simulator, users can specify nearly unlimited numbers of ‘virtual diabetic patients’ and test how different types of treatment, doses and dosing regimens, and even lifestyle (dietary) changes affect the daily BG profile. If a simulated regimen is found unable to keep glycaemia within desired limits, users can try alternative management regimens that seem to improve this daily pattern.
The circulating concentrations of glucose are normally maintained in health within a narrow range by homeostatic control mechanisms involving endocrine hormones, principally insulin and glucagon. Glucose metabolism involves a wide spectrum of transport and metabolic processes some of which are difficult to measure in vivo. Mathematical models, therefore, have the potential to play an important role in the identification and quantification of mechanisms.
Clinically relevant models describing the important metabolite and hormone dynamics in diabetic patients have been developed since the 1960s; for recent reviews see Makroglou (1) and Stahl et al. Model formulations vary in form and detail as primarily determined by their intended use. While the glucoregulatory system involves multiple metabolites and hormones, most existing models focus only on the dynamics of glucose and insulin (2-6). Various approaches have been used including ordinary differential equations, delayed differential equations, partial differential equations, and integro-differential equations (1).
Physiologically based models, with the body compartmentalized into physiological compartments representing the organs and tissues important in terms of glucose homeostasis. (7-9). The Sorensen (7) physiological model comprised a system of 22 mass balance equations, which predict glucose, insulin, and glucagon concentrations in each compartment. Puckett (8) developed a model very similar to Sorensen’s, but did not include glucagon’s effects, and removed all transport terms besides the metabolic sources and sinks. Farmer et al. developed a model framework to describe the biochemical species associated with glucose metabolism (9). Recently the Sorensen model was adapted for NIDDM patients (10). Different models have also been proposed to describe the dynamics of glucose absorption after meals and the absorption of insulin following sc injections of different insulin preparations. Mari et al. (11) proposed another model to describe insulin secretion involving the time delay between the glucose signal and insulin secretion.
Subcutaneous insulin absorption is a complex process which is affected by many factors including tissue blood flow, injection site/depth, injected volume and concentration (12). Insulin absorption from subcutaneous injection or infusion has been widely studied since Binder et al. (12). For a review see Nucci & Cobelli (13). Berger & Rodbard (14) prediction of plasma insulin levels for various insulin preparations. More on physiology and pharmacokinetics, has been described by Mosekilde and colleagues (15). This approach was later modified by Trajanowski et al. (16). The model was also extended to support monomeric insulin analogues (17-18).
The accumulated new knowledge and recent models have allowed the development of a comprehensive educational model of glucose homeostasis which is able to represent conditions typical for both IDDM and NIDDM patients. This article overviews the new model and provides a description of some of the model’s output.
Powyżej zamieściliśmy fragment artykułu, do którego możesz uzyskać pełny dostęp.
Mam kod dostępu
- Aby uzyskać płatny dostęp do pełnej treści powyższego artykułu albo wszystkich artykułów (w zależności od wybranej opcji), należy wprowadzić kod.
- Wprowadzając kod, akceptują Państwo treść Regulaminu oraz potwierdzają zapoznanie się z nim.
- Aby kupić kod proszę skorzystać z jednej z poniższych opcji.
- dostęp do tego artykułu
- dostęp na 7 dni
uzyskany kod musi być wprowadzony na stronie artykułu, do którego został wykupiony
- dostęp do tego i pozostałych ponad 7000 artykułów
- dostęp na 30 dni
- najpopularniejsza opcja
- dostęp do tego i pozostałych ponad 7000 artykułów
- dostęp na 90 dni
- oszczędzasz 28 zł
1. Makroglou A, Li J, Kuang Y: Mathematical models and software tools for the glucose-insulin regulatory system and diabetes: an overview. Applied Numerical Mathematics 2006; 56: 559-573. 2. Biermann E: DIACATOR: simulation of metabolic abnormalities of type II diabetes mellitus by use of a personal computer. Computer Methods & Programs in Biomedicine 1994; 41: 217-229. 3. Cobelli C, Nucci G, Del Prato S: A physiological simulation model of the glucose–insulin system in type I diabetes. Diabetes Nutrition & Metabolism 1998; 11: 78-80. 4. Guyton JR, Foster RO, Soeldner JS et al.: A model of glucose-insulin homeostasis in man that incorporates the heterogeneous fast pool theory of pancreatic insulin release. Diabetes 1978; 27: 1027-1042. 5. Mari A: Mathematical modeling in glucose metabolism and insulin secretion. Current Opinion Clinical Nutrition Metabolism Care 2002; 5: 495-501. 6. Rutscher A, Salzsieder E, Fischer U: KADIS: model aided education in type I diabetes. Computers Methods & Programs in Biomedicine 1994; 41: 205-215. 7. Sorensen JT: A physiologic model of glucose metabolism in man and its use to design and assess improved insulin therapies for diabetes. PhD Thesis. Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA 1985. 8. Puckett WR: Dynamic modelling of diabetes mellitus, PhD Dissertation, Department of Chemical Engineering, The University of Wisconsin-Madision, USA 1992. 9. Farmer TG: Intravenous closed-loop glucose control in type I diabetic patients. PhD Thesis, University of Texas at Austin, TX, USA 2007. 10. Vahidi O, Kwok KE, Gopaluni RB, Sun L: Development of a physiological model for patients with type 2 diabetes mellitus. Bioch Engin J 2011; 55: 7-16. 11. Mari A, Camastra S, Toschi E et al.: A model for glucose control of insulin secretion during 24 hours of free living. Diabetes 2001; 50 (Suppl. 1): S164-S168. 12. Binder C, Lauritzen T, Faber O, Pramming S: Insulin pharmacokinetics. Diabetes Care 1984; 7: 188-199. 13. Nucci G, Cobelli C: Models of subcutaneous insulin kinetics. A critical review. Computer Methods & Programs in Biomedicine 2000; 62: 249-257. 14. Berger M, Rodbard D: Computer simulation of plasma insulin and glucose dynamics after subcutaneous insulin injection. Diabetes Care 1989; 12: 725-736. 15. Mosekilde E, Jensen KS, Binder C et al.: Modeling absorption kinetics of subcutaneous injected soluble insulin. Journal of Pharmacokinetics & Biopharmaceuticals 1989; 17: 67-87. 16. Trajanowski Z, Wach P, Kotanko P wt al.: Pharmacokinetic model for the absorption of subcutaneously injected soluble insulin and monomeric insulin analogues. Biomedizinische Technik (Berl) 1993; 38: 224-231. 17. Tarín C, Teufel E, Picó J et al.: Comprehensive pharmacokinetic model of insulin Glargine and other insulin formulations. IEEE Transactions on Biomedical Engineering 2005; 52: 1994-2005. 18. Lehmann ED, Deutsch T, Broad D: AIDA: an educational simulator for insulin dosage and dietary adjustment in diabetes. London: British Diabetic Association 1997. 19. Lehmann ED, Tarín C, Bondia J wt al.: Incorporating a generic model of subcutaneous insulin absorption into the AIDA v4 diabetes simulator. Journal of Diabetes Science & Technology 2007; 1: 423-435 – 2007; 1: 780-793 – and – 2009; 3: 190-201.